NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Patients with ulcerative colitis in remission phase
Date of first enrollment	22/11/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Z-206 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Non-incidence of bloody stool
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 16age old
Age maximum	<= 64age old
Gender	Both
Include criteria	Patients with ulcerative colitis in remission phase who are defined to show Ulcerative Colitis-Disease Activity Index (UC-DAI) score of not less than 2 and bloody stool score of 0.
Exclude criteria